Predicting relapse after achieving a functional cure for chronic hepatitis B (CHB) using baseline HBsAg and end-of-treatment HBsAb levels - Han, Lianxiu; Wang, Zilong; Kang, Luyang; Cui, Xiaoling; Li, Yi; Yin, Huafa; Gao, Yufeng; Li, Jiabin (Scientific reports, 2025)
Keywords: 631/250/255; 692/699/255; Adult; Antiviral Agents - therapeutic use; Female; HBsAb; HBsAg; Hepatitis; Hepatitis B; Hepatitis B Antibodies - blood; Hepatitis B surface antigen; Hepatitis B Surface Antigens - blood; Hepatitis B Surface Antigens - immunology; Hepatitis B virus - immunology; Hepatitis B, Chronic - blood; Hepatitis B, Chronic - drug therapy; Hepatitis B, Chronic - immunology; Hepatitis B, Chronic - virology; Humanities and Social Sciences; Humans; Kaplan-Meier Estimate; Kaplan–Meier; Logistic regression analysis; Male; Middle Aged; multidisciplinary; Nomogram; Patients; Prediction models; Recurrence; Regression analysis; Retrospective Studies; Risk Factors; Science; Science (multidisciplinary); Survival; Survival analysis; Treatment Outcome; HBsAg; Logistic regression analysis; HBsAb; Kaplan–Meier; Nomogram